In a recent study with a small cohort (n = 14) of MS patients, NLRP3, ASC, caspase-1, IL-1β and IL-18 were found to be significantly upregulated in postmortem CNS tissue compared to non-MS controls [184]. This evidence concerns the gene IL18 and myeloid sarcoma.